Evidence map›Paper›PMID 40492498›Full record

ArticleJournal of psychopharmacology (Oxford, England)2026

A model training curriculum for psychedelic, psycholytic, and entactogen-assisted psychotherapy.

Torsten Passie, Anja Loizaga-Velder, Alicia Danforth, Charles S Grob, George R Greer, David Erritzoe, Peter Oehen, Juraj Styk, Michael Schlichting, Eric Vermetten and 12 more

Abstract read
In one paragraph

Article in Journal of psychopharmacology (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Torsten PassieHannover Medical School, Hannover, Germany.ORCID 0000-0002-6143-0560
Anja Loizaga-VelderNierika Institute for Intercultural Medicine, Ocuilan, Mexico.
Alicia DanforthThe Lundquist Institute, Harbor-UCLA Medical Center, Torrance, CA, USA.
Charles S GrobUCLA School of Medicine, Los Angeles, CA, USA.
George R GreerHeffter Research Institute, Greenwich, CT, USA.
David ErritzoeDivision of Psychiatry, Dept. Brain Sciences, Centres for Neuropsychopharmacology and Psychedelic Research, Imperial College London, London, UK.
Peter OehenPrivate Practice, Solothurn, Switzerland.
Juraj StykPrivate Practice, Basel, Switzerland.
Michael SchlichtingPrivate Practice, Basel, Switzerland.
Eric VermettenDept. Psychiatry, Leiden University Medical Center, Leiden, The Netherlands.
Ivar W GoksøyrØstfold Hospital Trust, Grålum, Norway.
Tomas PalenicekNational Institue of Mental Health, Klecany, Czech Republic.
Michael C MithoeferMedical University of South Carolina, SC and Columbia University, NY, USA.
Annie MithoeferPrivate Practice, Charleston, SC, USA.
Brian AndersonUCSF Department of Psychiatry and Behavioral Sciences, UC Berkeley Center for the Science of Psychedelics, Berkeley, CA, USA.
Erwin KredietARQ National Psychotrauma Center, Diemen, The Netherlands.
Peter GasserPrivate Practice, Solothurn, Switzerland.
Elizabeth M NielsonFluence International Inc, Woodstock, NY, USA.
Ingmar GormanFluence International Inc, Woodstock, NY, USA.
Janis PhelpsCenter for Psychedelic Therapies and Research, California Institute of Integral Studies, San Francisco, CA, USA.
Alexander B BelserYale School of Public Health, Yale University, New Haven, CT, USA.
Jeffrey GussNYU School of Medicine, New York, NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The authors offer a model for curriculum for education and training in substance-assisted psychotherapy (SAP), that is, psychedelic, psycholytic, and entactogen/MDMA (3,4-methylenedioxymethamphetamine)-assisted psychotherapy, addressing both the detailed contents of training and the question of experiential training. All authors of this model have an abiding interest and extensive experience in both the theory and practical aspects of SAP and questions relating to training. The model curriculum has been written through an international consensus building process and represents a consensus statement about the topic. The model includes an enumeration of theoretical themes and topics, which we suggest for inclusion in an SAP curriculum. The practical part of the curriculum includes experiential training with the following components: (1) apprenticeship observation: learning from observing experienced therapists, (2) ongoing clinical supervision: conducting treatment under direct supervision of experienced SAP therapists, and (3) a proposal for the inclusion of self-experiences for the trainees. Other parts address the use of peer supervision and conventional supervision. The authors are aware of the abiding need for respect of intercultural differences. We are conscious that the proposed model is one largely adapted to western industrialized countries with established graduate level education and training procedures for psychotherapists. However, the model curriculum includes teachings about the use of related substances and treatment techniques in indigenous cultures and traditions. This curriculum model may be valuable to psychedelic researchers, those endeavoring to train therapists for research studies, and those preparing for the clinical work to follow, once SAP is conducted outside of research settings.

Indexed as

CurriculumHallucinogensPsychotherapyHumansHallucinogenseducation of therapistsMDMA-assisted psychotherapyPsychedelic therapypsycholytic therapytherapists self-experiencetraining curriculum

Identifiers

PMID40492498
PMCPMC13291380

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.